UBS Group’s SANUWAVE Health Inc SNWV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Buy
256,791
+46,528
+22% +$721K ﹤0.01% 4876
2026
Q1
$3.64M Buy
210,263
+191,642
+1,029% +$4.73M ﹤0.01% 4396
2025
Q4
$556K Buy
18,621
+9,558
+105% +$307K ﹤0.01% 6008
2025
Q3
$340K Sell
9,063
-117
-1% -$4.33K ﹤0.01% 6358
2025
Q2
$302K Buy
+9,180
New +$277K ﹤0.01% 6434

Other funds holding SNWV

UBS Group's SNWV Position: Q2 2026 in Review

UBS Group increased its SANUWAVE Health Inc (SNWV) stake by 22% in Q2 2026, buying an estimated $721K and bringing the position to 256,791 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #4876.

UBS Group first reported a position in SNWV in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.64M in Q1 2026. 49 funds tracked by Wall St. Rank hold SNWV as of Q2 2026.

  • UBS Group held 256,791 shares of SANUWAVE Health Inc worth $2.57M as of Q2 2026.
  • UBS Group bought 46,528 SANUWAVE Health Inc shares in Q2 2026, an estimated $721K.
  • SANUWAVE Health Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4876 holding.
  • UBS Group first reported a position in SANUWAVE Health Inc in Q2 2025 and has held it in 5 quarters since.
  • UBS Group's SANUWAVE Health Inc position peaked at $3.64M in Q1 2026.
  • 49 funds tracked by Wall St. Rank held SANUWAVE Health Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.